IPPRA / Grant Monitor

2026-07-07
← Board

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

HT942526BCRPBTA12 · Defense Health Agency Contracting Activity - DHACA

biomedical clinical public health mental behavioral health Science & Technology R&D

Closes
2026-07-08 · 1 d
Award ceiling
Award floor
Program funding
$31,800,000
Expected awards
18
Cost sharing
No
Posted
2026-05-04
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

Supports high-impact breast cancer research projects that can lead to clinical application, at Funding Levels 1 or 2, including an optional population science studies track at Level 2.

Funds
applied research
University
direct
social behavioral
substantial
physical sciences
minor
engineering
minor
life biomedical
central
computational data
minor

⚑ Addresses FY26 BCRP overarching challenges or must justify exception · Single-PI or two-PI partnering option (Initiating PI/Partnering PI) · Partnering PI option requires pre-application from Initiating PI and full applications from both PIs; missing any associated submission can cause administrative withdrawal · Population science studies allowed only under Funding Level 2; may request higher funding and an additional year with strong justification

Unit fits — one characterization, each unit's own rules

IPPRA 58 good portfolio topics: public_health, mental_behavioral_health; social/behavioral work is substantial; funds applied research; clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Physical Sciences & Engineering (demo) 55 good technical depth: minor; funds applied research
Tom Love Innovation Hub 30 weak funds applied research; deep-tech content

Description

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2.

Distinctive Features:

· This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science Studies option. With compelling justification, population science studies may request higher levels of funding and an additional year in the period of performance.

· This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Apply

View on Grants.gov → CONTACT: Jamie Shortall Grant Officer <help@eBRAP.org>

Proposal brief

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · Department of Defense (BAA-style) conventions

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING

Legacy IPPRA LLM assessment (v2.0, for comparison)

35/100 · gpt-5.4-mini · 2026-07-06

This is a biomedical breast cancer research program, so the core topic is outside IPPRA’s main weather/energy/security/environment portfolio. The one notable opening is the Level 2 population science option, which could include behavioral, communication, or disparities research, but this remains primarily a clinical/biomedical award. Public universities appear eligible as research applicants, but the fit is still only tangential for IPPRA.

Legacy scoring history

2026-07-06 35 gpt-5.4-mini This is a biomedical breast cancer research program, so the core topic is outside IPPRA’s main weather/energy/security/environment portfolio. The one notable opening is the Level 2 population science option, which could include behavioral, communication, or disparities research, but this remains primarily a clinical/biomedical award. Public universities appear eligible as research applicants, but the fit is still only tangential for IPPRA.
2026-07-06 18 gpt-5.4-mini This is a breast cancer biomedical research program centered on clinical/biological breakthrough research. IPPRA’s strengths are in the human, behavioral, communication, and policy dimensions of technical systems, and the notice does not indicate a required or substantial social/behavioral, public health communication, or policy component. Public universities may apply, but the topic is outside IPPRA’s core portfolio, so the fit is weak.